Tachycardia Management

Management

Control Strategy for Atrial Fibrillation

Lenient heart rate (HR) control, compared to strict HR control, may be beneficial in patients with persistent atrial fibrillation who have stable ventricular function (LVEF >0.40) and/or no symptoms related to atrial fibrillation
- Lenient HR control is defined as achieving resting HR <110 beats per minute (bpm); strict HR control is <80 bpm at rest and HR <110 bpm during a 6-minute walk
- May be considered as the initial HR target for rate control therapy
- Left ventricular function should be monitored in these patients
One trial revealed that in patients with atrial fibrillation and systolic heart failure, routine strategy of rhythm control is not beneficial compared to rate control strategy

Dapagliflozin DELIVERs across full HF spectrum regardless of LVEF

Elvira Manzano, 04 Oct 2022

The selective, oral sodium–glucose cotransporter 2 (SGLT2) inhibitor dapagliflozin reduces the risk of cardiovascular (CV) death or worsening heart failure (HF) in patients with HF and mildly reduced or preserved ejection fraction (HFmrEF or HFpEF) in the phase III DELIVER* trial, touted as the largest and most inclusive thus far in this patient group.

Ticagrelor benefits in TWILIGHT hold up in diabetes

Roshini Claire Anthony, 23 Apr 2020

Dropping aspirin after 3 months of dual therapy with ticagrelor reduced bleeding in patients with diabetes who have undergone PCI* vs taking both agents for 1 year, the TWILIGHT-DM** study has shown, consistent with benefits seen in TWILIGHT for other high-risk patients.

HK in CKD: Do diet, HD frequency matter?

Elvira Manzano, 28 Jun 2020

Hyperkalaemia (HK) occurrence and recurrence are frequent in advanced CKD*, creating a perfect storm for cardiovascular events and death, says Professor Juan-Jesus Carrero from the Karolinska Institute, Solna, Sweden, at ERA-EDTA 2020. Given these risks, acutely elevated potassium (K+) should merit clinical attention.